What is Mint Neurotechnologies?
Mint Neurotechnologies operates at the intersection of neuroscience and microtechnology, pioneering the development of next-generation neural implants. By utilizing sophisticated semiconductor technology, the company aims to address complex neurological conditions with unprecedented precision. Their core value proposition lies in delivering high-performance neural interfaces that minimize surgical invasiveness, thereby improving patient outcomes and quality of life. The organization is backed by a multidisciplinary team of experts in neuroscience and implantable systems, ensuring a robust approach to solving some of the most challenging problems in modern medicine.
How much funding has Mint Neurotechnologies raised?
Mint Neurotechnologies has raised a total of $1.4M across 2 funding rounds:
Grant
$121K
Other Financing Round
$1.3M
Grant (2024): $121K with participation from UK Research & Innovation
Other Financing Round (2024): $1.3M led by Parkwalk Advisors, Empire Global Ventures, and Plug & Play
Key Investors in Mint Neurotechnologies
Parkwalk Advisors
Parkwalk is a leading investor in university spinouts, focusing on deeptech innovations emerging from the UK's top universities. They bridge the gap between academic research and commercial success by providing funding, expertise, and networks.
Empire Global Ventures
Empire Global Ventures is a business development team that focuses on helping clients achieve growth across various sectors, including health tech and sustainability. They provide comprehensive support to ensure projects are successfully launched and scaled.
Plug & Play
Plug & Play Solutions specializes in AI-driven security systems and innovative technology platforms. They are committed to delivering tailored solutions that integrate advanced technology to redefine safety and operational standards.
What's next for Mint Neurotechnologies?
With the recent influx of capital, Mint Neurotechnologies is well-positioned to scale its operations and advance its clinical trial pipeline. The strategic focus will likely shift toward regulatory approval processes and the refinement of its proprietary semiconductor architecture. As the company matures, it will need to navigate the complexities of the global medtech market, focusing on long-term scalability and the integration of its technology into standard clinical practice. The support from institutional investors suggests a strong commitment to long-term value creation in the neurotechnology sector.
See full Mint Neurotechnologies company page
